跳至主要内容
临床试验/ACTRN12616000992404
ACTRN12616000992404已完成未知

Effects of a lifestyle intervention in patients with Non-Alcoholic Fatty Liver Disease or Hepatitis C

Professor Jacob George0 个研究点目标入组 180 人开始时间: 2016年7月28日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Diagnosis of non-aldoholic fatty liver disease (NAFLD) or hepatitis C (and not receiving anti-viral therapy)
  • Males and females aged 18 years and over
  • Elevated ALT U/L) (>30 in males and >19 in females)

排除标准

  • Alcohol intake >30g per day in males or >20g per day in females
  • Current injecting drug use or unstable drug habit
  • Liver cancer
  • Severe Depression (HADDS Score)
  • Cushing's Syndrome
  • Chronic Pancreatitis
  • Other liver diseases identified by appropriate tests including Hepatitis B (negative for hepatitis B surface antigen), autoimmune liver disease (antinuclear antibody, antismooth muscle antibody, anti-liver kidney microsomal antibody and antimitochondrial antibody), Wilson's disease (serum copper and ceruloplasmin levels), alpha-1 antitrypsin deficiency (alpha-1 antitrypsin deficiency (alpha-1 antitrypsin levels and alpha-1 antitrypsin genotype) and hemochromatosis (iron studies and genotyping for C268Y and H63D mutations).

研究者

发起方
Professor Jacob George

相似试验